DBV Technologies | DBVT - Bénéfice Avant Impôts

Prix De L'Action
22.20
Variation Quotidienne
-0.59 -2.59%
Mensuellement
4.42%
Annuel
395.95%
Q1 Prévisions
20.46




Bénéfice Avant Impôts Changement Date
Acadia Pharmaceuticals USD 26.32M 18.28M 2025-12
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
Amarin USD -8.12M 5.34M 2025-09
BioCryst Pharmaceuticals USD -86.95M 73.5M 2024-12
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
DBV Technologies USD -33.16M 8.6M 2025-09
Esperion Therapeutics USD 67.66M 3.6M 2024-09
Galectin Therapeutics USD -12.37M 880K 2024-06
Halozyme Therapeutics USD 218.96M 14.02M 2025-09
Incyte USD 389.94M 92.37M 2025-12
Insmed USD -326.93M 41.77M 2025-12
Ionis Pharmaceuticals USD -228M 99M 2025-12
Neurocrine Biosciences USD 239.4M 52.4M 2025-12
PTC Therapeutics USD -139.08M 116.01M 2025-12
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
Ultragenyx Pharmaceutical USD -128M 51.54M 2025-12
United Therapeutics USD 444M 6M 2025-12